Christopher Hoffmann, MD

Faculty

Titles:

Assistant Professor, Medicine

SciVal:

SciVal Link

Dr Hoffmann is an Assistant Professor of Medicine in the Division of Infectious Diseases with a joint appointment in the Division of Internal Medicine.  His clinical work includes inpatient and outpatient HIV care and inpatient general infectious diseases consults and general internal medicine.  His primary research interest is in reducing HIV and TB associated mortality in low and middle income countries.  He work spans several disciplines including (1) clinical epidemiology and clinical outcomes related research with HIV treatment cohorts, (2) population-level epidemiology of TB, HIV, and hepatitis B, (3) operational research around screening and testing for both TB and HIV (including in marginalized populations such as correctional facility inmates), (4) implementation science to understand and improve scale-up of proven interventions through the use of pragmatic clinical trials, (5) health economics to contextualize operational research and implementation science findings. The majority of his work is in southern Africa.  Current projects include assessments of interventions to increase entry-into-care following HIV diagnosis, retention in HIV care, managing HIV and TB care transitions, improved TB intensified case finding, TB and HIV management in correctional facilities, and adapting quality improvement approaches for primary health clinics in South Africa.  He is also involved in several projects aimed at assessing current HIV care with the goal of contributing to improving outcomes while using existing antiretroviral agents and delivery infrastructure. I also teach a module on global health delivery at the School of Medicine.

Categories

Events

«

January 2020

»
S
M
T
W
T
F
S
·
·
·
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
·

Projects

Statins as adjunctive host-directed therapy...

This study will investigate the role of statins in combination with the first-line regimen for TB in the mouse model. In...

Read More

A Comprehensive Snapshot of Tuberculosis...

This study aims to find all cases of TB within an urban Ugandan community of 50,000 people and to characterize both the...

Read More

Understanding the impact of combined TB and...

We are developing models to understand the overlap of TB and HIV in three epidemiologically distinct settings (Canada, India,...

Read More

A novel “shock and kill” strategy...

The objective of this study is to determine if pharmacological inhibition of the Mtb stringent response leads to accelerated...

Read More

APT: Assessing PA-824 for Tuberculosis

A Phase 2 clinical trial of PA-824, an investigational nitroimidazole, as part of multidrug therapy for pulmonary TB; in...

Read More